الصفحة 1 من عند 22 النتائج
BACKGROUND OF THE INVENTION
Pathological inflammation is emerging as an underlying mechanism for numerous diseases. For example, the major forms of idiopathic IBD, ulcerative colitis and Crohn's disease are chronic inflammatory disorders of the gastrointestinal tract. Animal studies have shown that
BACKGROUND OF THE INVENTION
Pathological inflammation is emerging as an underlying mechanism for numerous diseases. For example, the major forms of idiopathic IBD, ulcerative colitis and Crohn's disease are chronic inflammatory disorders of the gastrointestinal tract. Animal studies have shown that
BACKGROUND OF THE INVENTION
Pathological inflammation is emerging as an underlying mechanism for numerous diseases. For example, the major forms of idiopathic IBD, ulcerative colitis and Crohn's disease are chronic inflammatory disorders of the gastrointestinal tract. Animal studies have shown that
FIELD OF THE INVENTION
This invention relates to novel compositions-of-matter, methods for their manufacture, pharmaceutical formulations thereof and the method of using said formulations in the treatment and control of acne vulgaris.
More specifically, this invention relates to novel retinoic acid
FIELD OF INVENTION
The present invention is directed to compounds, their synthesis, and their use as antagonists, inverse agonists, modulators and or inhibitors of the Retinoic acid-related Orphan nuclear Receptor .gamma.t (ROR.gamma.t)/ROR.gamma.. In particular, the present invention is directed to
FIELD OF INVENTION
The present invention is directed to compounds, their synthesis, and their use as antagonists, inverse agonists, modulators and or inhibitors of the Retinoic acid-related Orphan nuclear Receptor .gamma.t (ROR.gamma.t)/ROR.gamma.. In particular, the present invention is directed to
FIELD OF INVENTION
The present invention is directed to compounds, their synthesis, and their use as antagonists, inverse agonists, modulators and or inhibitors of the Retinoic acid-related Orphan nuclear Receptor .gamma.t (ROR.gamma.t)/ROR.gamma.. In particular, the present invention is directed to
BACKGROUND OF THE INVENTION
The present invention relates to a method of treating noninflammatory acne.
Acne vulgaris is a common dermatological disorder which affects large patient populations in the preadolescent, adolescent and young adult age groups. Since it occurs primarily in the face and
FIELD OF THE INVENTION
The present invention relates to a method for treatment of musculoskeletal and connective tissue inflammations. More specifically, the method utilizes 13 cis-retinoic acid to effectively treat musculoskeletal and connective tissue inflammations including osteoarthritis and
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims priority to the PCT Application PCT/EP2015/067713 filed on 31 Jul. 2015 which further claims the priority of Swedish Patent Application No. SE 2014/0051406 filed on 21 Nov. 2014 in the Sweden Patent and Trademark Office, and Swedish
BACKGROUND
Field
The present embodiments relate to compositions and methods for modulating Retinoic Acid Receptor (RAR) in the prevention and treatment of inflammatory conditions of the liver.
Description of the Related Art
Excessive alcohol use is a major cause of liver disease in the Western
FIELD
The invention concerns particle formulations of all-trans retinoic acid and transforming growth factor beta for the treatment of autoimmune diseases, such as type I diabetes mellitus. Methods of making and using the particle formulations are also disclosed.
BACKGROUND
Autoimmune diseases may
CROSS-REFERENCE TO RELATED APPLICATIONS
The present application is a 35 U.S.C. .sctn. 371 national phase application from, and claims priority to, International Application No. PCT/GB2015/053183, filed Oct. 23, 2015, and published under PCT Article 21(2) in English, which claims priority to GB
BACKGROUND OF THE INVENTION
1. Field of the Invention
A wide variety of skin diseases are characterized by abnormal metabolic processes. Two classes of these conditions are the seborrheic dermatoses--which are typified by excessive secretion or disturbed quality of sebum, abnormal intercellular
BACKGROUND OF THE INVENTION
1. Field of the Invention
A wide variety of skin diseases are characterized by abnormal metabolic processes. Two classes of these conditions are the seborrheic dermatoses--which are typified by excessive secretion or disturbed quality of sebum, abnormal intercellular